Endo Announces Agreement For Paladin Pharma To Commercialize Wynzora® Cream In Canada
MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Endo, Inc.: Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora Cream in Canada
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
US Weekly on MSN19h
After Years of Trying, These Are My 25 Favorite Lotions for Dry Skin
Around 30% of the population suffers from dry skin, and I’m definitely among them — especially in the brutally cold winter ...
Too Old to Operate7h
JNJ-77242113 Demonstrates Sustained Skin Clearance in Psoriasis
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
BuzzFeed on MSN19h
30 Products That Have Over 10,000 5-Star Reviews For A Reason
Just check out some of the before and after photos posted among the 28,000 5-star reviews! 3.A moisturizing liquid lipstick ...